Equities

Little Green Pharma Ltd

LGP:ASX

Little Green Pharma Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (AUD)0.13
  • Today's Change0.00 / 0.00%
  • Shares traded230.50k
  • 1 Year change-25.71%
  • Beta1.5564
Data delayed at least 20 minutes, as of May 03 2024 07:10 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Little Green Pharma Ltd is a global, vertically integrated and geographically diverse medicinal cannabis business with operations from cultivation and production through to manufacturing and distribution. The Company has two global production sites for the manufacture of its own-branded and white-label ranges of Good Manufacturing Practice (GMP)-grade medicinal cannabis products, being a 21,500 square meters cultivation and 4,000 square meters GMP manufacturing facility capable of producing over 30 tons of medicinal cannabis biomass per annum located in Denmark (EU) and an indoor cultivation and manufacturing facility located in Western Australia capable of producing three tons of medicinal cannabis biomass per annum. The Company focuses on patient access in the global medicinal cannabis market and is actively engaged in promoting education and outreach programs, as well as participating in clinical investigations and research projects to develop new delivery systems.

  • Revenue in AUD (TTM)23.24m
  • Net income in AUD-3.14m
  • Incorporated2016
  • Employees--
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Lumos Diagnostics Holdings Ltd12.52m-13.44m23.58m----1.68--1.88-0.0361-0.03610.03560.02920.34182.246.37---36.70-40.15-55.14-56.6759.7345.97-107.38-162.900.479-6.250.4803---9.4239.2980.38---38.50--
Chimeric Therapeutics Ltd0.00-11.31m24.70m----1.52-----0.027-0.0270.000.01910.00-------45.96---69.36-------------10.010.1596-------60.40------
LBT Innovations Limited2.00m-21.38m25.45m17.00--9.38--12.70-0.0428-0.04280.00380.0020.10870.08192.25117,882.40-115.89-28.85-131.86-30.9994.76---1,066.62-441.763.30-6.850.5633---5.29-18.45-239.17---34.63--
Alterity Therapeutics Ltd123.46k-12.28m26.23m11.00--0.7951--212.42-0.005-0.0050.000050.00630.0044--1.5211,223.64-44.20-53.02-53.57-61.96-----9,947.97-40,995.62----0.0143--557.60-39.40-7.47---34.88--
BPH Energy Ltd345.67k894.65k26.34m2.00k24.491.18--76.200.0010.0010.00040.02030.0177--5.97--4.58-6.894.78-7.7256.39--258.50-357.76----0.0043--96.545.21179.13------
Cann Group Ltd16.45m-29.28m27.12m40.00--0.5339--1.65-0.0724-0.07240.04060.11610.12370.39527.37---22.03-22.28-34.23-24.4321.11---178.07-407.570.0861-5.880.5646--114.9089.76-27.66---11.16--
Invion Ltd4.46m-1.50m32.12m8.00--1.80--7.20-0.0002-0.00020.00070.00280.2345--3.20---7.88-16.93-8.12-18.13-----33.60-51.63----0.00--25.7241.1827.95------
IDT Australia Limited10.36m-6.55m32.51m156.00--1.41--3.14-0.022-0.0220.0350.06560.37412.393.51---23.64-9.87-26.41-11.5776.3884.42-63.19-24.942.81--0.0907---42.03-11.97-632.59---26.04--
Prescient Therapeutics Ltd697.94k-7.74m37.04m3.00--1.64--53.08-0.0098-0.00980.00090.02810.0276--2.32---30.58-27.61-32.59-29.03-----1,109.58-3,284.78---412.910.00--939.1629.68-36.88------
Little Green Pharma Ltd23.24m-3.14m39.23m----0.483558.711.69-0.011-0.01260.08330.26890.2631.1312.06---3.55---4.01--51.02---13.51--2.03-21.270.0667--------------
Cynata Therapeutics Ltd436.25k-13.65m43.11m0.00--3.51--98.82-0.0873-0.08730.00270.06830.0257--4.26---80.33-38.07-87.15-41.10-----3,127.93-513.73----0.00---94.9619.81-162.20------
Inoviq Ltd751.54k-6.51m45.55m85.00--2.72--60.61-0.0708-0.07080.00820.1820.03392.100.873---29.33-47.68-32.18-50.7695.07---866.27-2,527.824.93--0.0332--119.59153.3150.71------
Biotron Ltd1.65m-4.02m48.72m4.00--26.06--29.62-0.0045-0.00450.00180.00210.3587-------87.73-64.30-103.46-74.43-156.30-108.03-244.54-231.62----0.0148---8.16-2.48-25.59------
Starpharma Holdings Ltd10.63m-8.40m49.44m50.00--1.43--4.65-0.0205-0.02050.02590.08370.20920.2822.10---16.53-28.47-20.70-33.6692.6771.62-79.00-391.825.22--0.0833---14.10-3.223.19--11.58--
Anteotech Ltd526.75k-11.46m50.58m40.00--9.71--96.02-0.0056-0.00560.00030.00220.0552--2.62---120.11-68.55-145.22-75.44-----2,176.15-1,432.10----0.1729---46.6511.41-18.08--25.84--
Data as of May 03 2024. Currency figures normalised to Little Green Pharma Ltd's reporting currency: Australian Dollar AUD

Institutional shareholders

8.32%Per cent of shares held by top holders
HolderShares% Held
Thorney Investment Group Australia Pty Ltd.as of 10 Mar 202324.98m8.32%
Data from 24 Apr 2024 - 24 Apr 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.